LGND LIGAND PHARMACEUTICALS INC: institutional ownership and insider trading
444 funds reported holding $7.90B of LIGAND PHARMACEUTICALS INC in their latest 13F filings; in Q2 2026 funds net bought $571M, with 95 new positions and 32 funds selling out; over the last 12 months insiders bought $0 and sold $34.7M on the open market.
Famous investors holding LGND
- D. E. Shaw (D. E. Shaw & Co.): $21.3M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $5.95M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.70M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.26M, 0.0% of the portfolio
Largest institutional holders of LGND
- BlackRock, Inc. (BLK) — $980M
- VANGUARD GROUP INC — $392M
- Invesco Ltd. (IVZ) — $380M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $360M
- Jupiter Topco LLC — $329M
- VANGUARD CAPITAL MANAGEMENT LLC — $275M
- STATE STREET CORP (STT, STT-PG) — $261M
- FMR LLC — $241M
- FRANKLIN RESOURCES INC (BEN) — $238M
- CONGRESS ASSET MANAGEMENT CO — $206M
Recent LGND insider trades
- Oct 2, 2026: Reardon Andrew sold 5,000 shares ($1.52M)
- Sep 10, 2026: Zimmermann Martine sold 1,200 shares ($342K)
- Sep 3, 2026: Reardon Andrew sold 5,000 shares ($1.43M)
- Aug 12, 2026: Haas Jason sold 7,138 shares ($2.09M)
Members of Congress trading LGND
- May 29, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Mar 3, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Jan 15, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Jan 5, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
5%+ owners
- Invesco Ltd.: 6.1% (Schedule 13G, filed Aug 13, 2026)
- Vanguard Portfolio Management: 5.6% (Schedule 13G, filed May 1, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed May 1, 2026)